| Literature DB >> 25100324 |
Angela Maria Cusano1, Filippo Causa2, Raffaella Della Moglie1, Nunzia Falco1, Pasqualina Liana Scognamiglio1, Anna Aliberti1, Raffaele Vecchione1, Edmondo Battista1, Daniela Marasco3, Marika Savarese4, Umberto Raucci5, Nadia Rega6, Paolo Antonio Netti7.
Abstract
In this paper, we report on a general approach for the detection of a specific tumoural biomarker directly in serum. Such detection is made possible using a protein-binding peptide selected through an improved phage display technique and then conjugated to engineered microparticles (MPs). Protein biomarkers represent an unlimited source of information for non-invasive diagnostic and prognostic tests; MP-based assays are becoming largely used in manipulation of soluble biomarkers, but their direct use in serum is hampered by the complex biomolecular environment. Our technique overcomes the current limitations as it produces a selective MP--engineered with an antifouling layer--that 'captures' the relevant protein staying impervious to the background. Our system succeeds in fishing-out the human tumour necrosis factor alpha directly in serum with a high selectivity degree. Our method could have great impact in soluble protein manipulation and detection for a wide variety of diagnostic applications.Entities:
Keywords: microparticles for diagnosis; phage display selection; soluble cancer biomarker
Mesh:
Substances:
Year: 2014 PMID: 25100324 PMCID: PMC4233757 DOI: 10.1098/rsif.2014.0718
Source DB: PubMed Journal: J R Soc Interface ISSN: 1742-5662 Impact factor: 4.118